Autologous mitochondrial transplant for acute cerebral ischemia: Phase 1 trial results and review

Melanie Walker,Michael R Levitt,Emma M Federico,Francisco Javier Miralles,Sam HS Levy,Keiko Lynne Prijoles,Ashtyn Winter,Jennifer K Swicord,Yasemin Sancak
DOI: https://doi.org/10.1177/0271678x241305230
2024-12-05
Journal of Cerebral Blood Flow & Metabolism
Abstract:Journal of Cerebral Blood Flow &Metabolism, Ahead of Print. The results of a Phase 1 trial of autologous mitochondrial transplantation for the treatment of acute ischemic stroke during mechanical thrombectomy are presented. Standardized methods were used to isolate viable autologous mitochondria in the acute clinical setting, allowing for timely transplantation within the ischemic window. No significant adverse events were observed with the endovascular approach during reperfusion therapy. Safety outcomes in study participants were comparable to those of matched controls who did not undergo transplantation. This study represents the first use of mitochondrial transplantation in the human brain, highlighting specific logistical challenges related to the acute clinical setting, such as limited tissue samples and constrained time for isolation and transplantation. We also review the opportunities and challenges associated with further clinical translation of mitochondrial transplantation in the context of acute cerebral ischemia and beyond.
neurosciences,endocrinology & metabolism,hematology
What problem does this paper attempt to address?